Blog

Company News

Industry Trends

Laws Regulations

All Categories >

21

2022-05

Analysis of Shanghai’s April Economic Performance

Due to the impact of the pandemic, Shanghai has implemented district-based static management since 5:00 a.m. on March 28, with the Huangpu River serving as the dividing line, until recently when enterprises began to resume work and production. On May 19, the Shanghai Municipal Bureau of Statistics released economic performance data for April. In April 2022, industrial enterprises above designated size in our city (hereinafter referred to as “industry”) recorded a total industrial output value of RMB 128.617 billion, a year-on-year decrease of 61.5%.

2022-05-21

He Yousheng

08

2022-05

A Trillion-Yuan Blue-Ocean Market: COVID-19 Antigen Self-Testing

To further optimize COVID-19 testing strategies in light of epidemic prevention and control needs, the Comprehensive Group of the State Council Joint Prevention and Control Mechanism has decided to promote a monitoring model of “antigen screening combined with nucleic acid diagnosis,” supplementing nucleic acid testing with antigen testing. On March 11, the Comprehensive Group issued the “Trial Implementation Plan for the Application of COVID-19 Antigen Testing” (hereinafter referred to as the “Plan”), requiring all localities to conscientiously organize and implement it.

2022-05-08

He Yousheng

08

2022-05

This is the best of times for biopharmaceutical CDMOs; this is the worst of times for biopharmaceutical CDMOs.

As another year draws to a close, a review of the domestic biopharmaceutical CDMO sector in 2021 reveals a remarkably dynamic and diverse landscape. Some companies have been acquired, others have secured substantial financing to expand production capacity, some have attracted equity investments from listed firms, while several listed pharmaceutical companies have embarked on strategic transformations to enter the biopharmaceutical CDMO business. A number of firms have already submitted IPO applications that have been accepted for review, others are currently undergoing pre-IPO guidance, and some local industrial parks have established dedicated biopharmaceutical CDMO platforms and awarded contracts to professional operators. Meanwhile, an increasing number of biopharmaceutical companies are venturing into the CDMO space. At present, the industry’s development can only be described as characterized by “intense internal competition” and “unprecedented prosperity.”

2022-05-08

He Yousheng

15

2021-09

Administrative Measures for Researcher-Initiated Clinical Research Conducted by Medical and Health Institutions (Trial)

Recently, the National Health Commission convened a kickoff meeting in Beijing for the pilot program on standardized management of clinical research in medical and health institutions, at which it officially released the Measures for the Administration of Investigator-Initiated Clinical Research Conducted by Medical and Health Institutions (Trial) and announced that the measures would be implemented on a pilot basis starting October 1, 2021, in Beijing, Shanghai, Guangdong Province, and Hainan Province.

2021-09-15

He Yousheng

15

2021-09

Genetic Office Announces Dates for Approval Meetings in the Second Half of 2021

To further enhance the quality of administrative approval services for human genetic resources and to enable applicants to better track the progress of their applications, the scheduled dates for the Administrative Licensing Review Meetings of the China Office for the Administration of Human Genetic Resources in the second half of 2021 are hereby announced. Should special circumstances necessitate adjustments to the meeting schedule, advance notice will be provided.

2021-09-15

He Yousheng

15

2021-09

Q&A with Journalists on the Regulations of the People’s Republic of China on the Administration of Human Genetic Resources

On May 28, 2019, Premier Li Keqiang signed State Council Order No. 717, promulgating the Regulations of the People’s Republic of China on the Administration of Human Genetic Resources (hereinafter referred to as the “Regulations”). The Regulations came into effect on July 1, 2019. Recently, officials from the Ministry of Justice and the Ministry of Science and Technology answered questions from reporters on matters related to the Regulations.

2021-09-15

He Yousheng
< 1...20212223 >